Presentation THT 2022

Should SGLT2 Inhibitors Be Started in the Hospital or in the Ambulatory Setting?

Presenter: Piotr Ponikowski

February 01, 2022

REGISTER for free or LOG IN to view this content

Should SGLT2 Inhibitors Be Started in the Hospital or in the Ambulatory Setting?

Heart Failure

THT 2022

Heart Failure

Up Next

Presentation THT 2022

Disparities in Access to Technology

Presenter: Alanna Morris

February 01, 2022

More slides +

Presentation THT 2022

How to Improve Diversity in Heart Failure: Patients, Investigators, Trials

Presenter: Alanna Morris

February 01, 2022

Presentation THT 2022

CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Presenter: Sanjiv Shah

February 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.